In vivo cancer gene therapy with a recombinant interleukin-2 adenovirus vector

Cancer Gene Therapy

Volumn 3, Issue 1, 1996, Pages 11-17

  Toloza, Eric M ^a  

^a Division of Surgical Oncology   (United States)

Author keywords

Adenovirus; Fibrosarcoma; cancer; Interleukin 2

Indexed keywords

INTERLEUKIN 2;

ADENOVIRUS; ANIMAL; ARTICLE; C3H MOUSE; CELL CULTURE; ENHANCER REGION; EXPERIMENTAL NEOPLASM; FIBROSARCOMA; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; METHODOLOGY; MOUSE; PATHOLOGY; PROMOTER REGION; REPORTER GENE;

ADENOVIRIDAE; ANIMALS; ENHANCER ELEMENTS (GENETICS); FIBROSARCOMA; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; INTERLEUKIN-2; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOPLASMS, EXPERIMENTAL; PROMOTER REGIONS (GENETICS); TUMOR CELLS, CULTURED;

EID: 0029691138     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Miller AR, McBride WH, Hunt K, et al. Cytokine-mediated gene therapy for cancer. Ann Surg Oncol. 1994;1:436-450.
2. Economou JS, Toloza EM. Advances in gene therapy of cancer. In: Anderson DK, ed. Master Series in Surgery. Vol. VI: Advances In Surgical Gene Therapy. Cedar Knolls, NJ: World Medical Communications Organization; 1995: 61-76.
3. Foa R, Guarini A, Gansbacher B. IL-2 treatment for cancer: from biology to gene therapy. Br J Cancer. 1992; 66:992-998.
4. Visseren MJ, Koot M, van der Voort EI, et al. Production of interleukin-2 by EL4 tumor cells induces natural killer cell- and T-cell-mediated immunity.J Immunother Emphasis Tumor Immunol. 1994;15:119-128.
5. Karp SE, Farber A, Salo JC, et al. Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. J Immunol. 1993;150:896-908.